ENDRA Life Sciences Inc. — Director's Dealing 2025

Jul 1, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2025-06-11

Reporting Person: Basenese Lou (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-11	Common Stock	A	5384	—	Acquired	5385	Direct

Footnotes

F1: Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026.